Portfolio (Quarterly)
Guide ↗
BAILARD, INC.
· CIK 0000750641| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 721 | PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | 18,100.0 | $116K | 0.00% | NEW | — | $6.39 | +14.7% |
| 722 | EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | 13,600.0 | $113K | 0.00% | NEW | — | $8.30 | +0.2% |
| 723 | ORMP | ORAMED PHARMACEUTICALS INC | Healthcare | 32,478.0 | $110K | 0.00% | NEW | — | $3.40 | +13.8% |
| 724 | BDTX | BLACK DIAMOND THERAPEUTICS I | Healthcare | 51,500.0 | $110K | 0.00% | NEW | — | $2.13 | -17.8% |
| 725 | WHWK | WHITEHAWK THERAPEUTICS INC | Healthcare | 31,398.0 | $108K | 0.00% | NEW | — | $3.45 | +17.7% |
| 726 | NAGE | NIAGEN BIOSCIENCE INC | Healthcare | 23,800.0 | $105K | 0.00% | +7K | +42.5% | $4.41 | -21.8% |
| 727 | TARA | PROTARA THERAPEUTICS INC | Healthcare | 18,617.0 | $97K | 0.00% | -6K | -23.8% | $5.21 | -25.1% |
| 728 | FULC | FULCRUM THERAPEUTICS INC | Healthcare | 11,781.0 | $90K | 0.00% | — | — | $7.67 | -55.0% |
| 729 | ORGO | ORGANOGENESIS HLDGS INC | Healthcare | 36,812.0 | $87K | 0.00% | — | — | $2.37 | -1.3% |
| 730 | CTKB | CYTEK BIOSCIENCES INC | Healthcare | 19,900.0 | $87K | 0.00% | -9K | -32.1% | $4.37 | -9.4% |
| 731 | LTRX | LANTRONIX INC | Technology | 15,600.0 | $82K | 0.00% | -33K | -68.1% | $5.24 | +28.1% |
| 732 | RPD | RAPID7 INC | Technology | 14,100.0 | $78K | 0.00% | — | — | $5.51 | +29.6% |
| 733 | NHS | NEUBERGER HIGH YIELD ST FD I | Financial Services | 10,839.0 | $70K | 0.00% | — | — | $6.48 | -2.3% |
| 734 | ICCC | IMMUCELL CORP | Healthcare | 10,102.0 | $64K | 0.00% | NEW | — | $6.33 | +52.9% |
| 735 | IPWR | IDEAL PWR INC | Industrials | 20,365.0 | $58K | 0.00% | — | — | $2.83 | +115.5% |
| 736 | SURG | SURGEPAYS INC | Technology | 27,975.0 | $21K | — | — | — | $0.75 | -46.8% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
32.0%
Financial Services
22.2%
Healthcare
11.2%
Communication Services
9.1%
Industrials
7.0%
Consumer Cyclical
6.8%
Consumer Defensive
4.0%
Energy
3.3%
Basic Materials
2.1%
Utilities
1.2%